Epizyme's Series B - II Round

Epizyme raised a round of funding on December 10, 2009.

Epizyme is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers. Epizyme has built a product platform that the company uses to cr…

Articles about Epizyme's Series B - II Round: